REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical Study

Summary

The primary objective is to compare \& evaluate between the treatment groups the changes in decline/reduction of HIV viral load \& increase changes in WBC white blood cell counts in the adult Remune dose vs the low dose Remune placebo groups. Additional objectives include changes in CD4+ \& CD8+ T cell counts along with increased HIV immunity.

Timeline

Start

2017-11

Primary completion

2019-11

Completion

2019-11

Drugs

Indications